Skip to main navigation Skip to search Skip to main content

A Randomized, Double blind, Parallel Group, Multi center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Out

Project Details

StatusActive
Effective start/end date15/09/24 → 30/09/27

Funding

  • AstraZeneca: A$61,077.00